InsiderClue
Insiders · Profile

DOYLE WILLIAM F

Executive Chairman at NovoCure · Director at Elanco Animal Health · Director at Minerva Neurosciences. Filing since 10 Sep 2018. CIK 0001194459

NVCR NovoCure Ltd Executive Chairman · 27 trades ELAN Elanco Animal Health Inc Director · 2 trades NERV Minerva Neurosciences, Inc. Director · 11 trades
Company
Date
Role
Action
Shares
Amount
Of holding
NVCR NovoCure Ltd
3 Mar 2026
Executive Chairman
Sold at will
71,887
$932.88K
18.0%
ELAN Elanco Animal Health Inc
21 May 2024
Director
Bought
15,000
$254.70K
24.5%
ELAN Elanco Animal Health Inc
8 Mar 2024
Director
Bought
15,000
$244.50K
32.4%
NVCR NovoCure Ltd
2 Aug 2022
Executive Chairman
Sold, plan not stated
837
$58.30K
0.2%
NVCR NovoCure Ltd
8 Mar 2022
Executive Chairman
Sold, plan not stated
2,385
$167.19K
0.4%
NVCR NovoCure Ltd
2 Aug 2021
Executive Chairman
Sold, plan not stated
995
$148.63K
0.2%
NVCR NovoCure Ltd
13 Apr 2021
Executive Chairman
Sold, plan not stated
95,000
$18.96M
14.6%
NVCR NovoCure Ltd
1 Apr 2021
Executive Chairman
Sold, plan not stated
7,928
$1.06M
1.2%
NVCR NovoCure Ltd
31 Jul 2020
Executive Chairman
Sold, plan not stated
896
$68.44K
0.1%
NVCR NovoCure Ltd
11 May 2020
Executive Chairman
Sold, plan not stated
31,332
$2.00M
4.6%
NVCR NovoCure Ltd
8 May 2020
Executive Chairman
Sold, plan not stated
31,903
$2.03M
4.5%
NVCR NovoCure Ltd
7 May 2020
Executive Chairman
Sold, plan not stated
30,993
$2.01M
4.5%
NVCR NovoCure Ltd
6 May 2020
Executive Chairman
Sold, plan not stated
29,881
$1.92M
5.0%
NVCR NovoCure Ltd
5 May 2020
Executive Chairman
Sold, plan not stated
30,283
$1.89M
4.8%
NVCR NovoCure Ltd
6 Mar 2020
Executive Chairman
Sold, plan not stated
4,320
$300.39K
0.8%
NVCR NovoCure Ltd
28 Feb 2020
Executive Chairman
Sold, plan not stated
3,893
$281.13K
0.8%
NVCR NovoCure Ltd
17 Jan 2020
Executive Chairman
Sold, plan not stated
133,777
$12.71M
20.8%
NVCR NovoCure Ltd
25 Nov 2019
Executive Chairman
Sold, plan not stated
16,223
$1.56M
2.5%
NVCR NovoCure Ltd
20 Nov 2019
Executive Chairman
Sold, plan not stated
150,000
$13.55M
18.5%
NVCR NovoCure Ltd
12 Nov 2019
Executive Chairman
Sold, plan not stated
13,218
$1.08M
1.6%
NVCR NovoCure Ltd
11 Nov 2019
Executive Chairman
Sold, plan not stated
29,782
$2.39M
3.5%
NERV Minerva Neurosciences, Inc.
27 Jun 2019
Director
Bought
3,500
$19.25K
15.5%
NVCR NovoCure Ltd
30 May 2019
Executive Chairman
Sold, plan not stated
48,100
$2.55M
5.4%
NVCR NovoCure Ltd
29 May 2019
Executive Chairman
Sold, plan not stated
1,900
$100.88K
0.2%
NVCR NovoCure Ltd
9 May 2019
Executive Chairman
Sold, plan not stated
31,460
$1.49M
3.4%
NVCR NovoCure Ltd
8 May 2019
Executive Chairman
Sold, plan not stated
32,218
$1.53M
3.6%
NVCR NovoCure Ltd
7 May 2019
Executive Chairman
Sold, plan not stated
32,098
$1.53M
3.7%
NVCR NovoCure Ltd
6 May 2019
Executive Chairman
Sold, plan not stated
29,038
$1.40M
3.4%
NVCR NovoCure Ltd
3 May 2019
Executive Chairman
Sold, plan not stated
29,966
$1.35M
3.7%
NVCR NovoCure Ltd
28 Feb 2019
Executive Chairman
Sold, plan not stated
3,097
$166.25K
0.3%
NERV Minerva Neurosciences, Inc.
20 Dec 2018
Director
Bought
2,000
$13.00K
9.7%
NERV Minerva Neurosciences, Inc.
11 Dec 2018
Director
Bought
4,000
$31.80K
24.1%
NERV Minerva Neurosciences, Inc.
10 Dec 2018
Director
Bought
2,000
$16.00K
13.7%
NERV Minerva Neurosciences, Inc.
20 Nov 2018
Director
Bought
2,000
$16.40K
15.9%
NERV Minerva Neurosciences, Inc.
11 Oct 2018
Director
Bought
600
$6.00K
5.0%
NERV Minerva Neurosciences, Inc.
17 Sep 2018
Director
Bought
1,800
$18.90K
17.6%
NERV Minerva Neurosciences, Inc.
14 Sep 2018
Director
Bought
200
$2.10K
2.0%
NERV Minerva Neurosciences, Inc.
13 Sep 2018
Director
Bought
2,000
$21.00K
25.0%
NERV Minerva Neurosciences, Inc.
11 Sep 2018
Director
Bought
4,011
$38.99K
100%
NERV Minerva Neurosciences, Inc.
10 Sep 2018
Director
Bought
4,000
$39.52K
opened
40 decisions on file.